NCT03066206 2026-02-20
Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC
M.D. Anderson Cancer Center
Phase 2 Terminated
M.D. Anderson Cancer Center
Seoul National University Hospital
Yonsei University
Yonsei University
Korean Association for the Study of Targeted Therapy
National OncoVenture